Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology.
Background: ALK-rearranged lung cancers exhibit specific pathologic and clinical features and are responsive to anti-ALK therapies. Therefore, the detection of ALK-rearrangement is fundamental for personalized lung cancer therapy. Recently, new molecular techniques, such as NanoString nCounter, have...
| Published in: | BMC Pulmonary Medicine Vol. 17; pp. 1 - 9 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | pictorial research tables/charts Journal Article |
| Published: |
BioMed Central
5/26/2017
|
| Online Access: | View this record in EBSCOhost |